Related Experiment Video
Updated: May 28, 2026

Establishment and Characterization of UTI and CAUTI in a Mouse Model
Published on: June 23, 2015
Antimicrobials in urogenital infections
Florian M E Wagenlehner1, Björn Wullt, Gianpaolo Perletti
1Department of Urology, Pediatric Urology and Andrology, Justus-Liebig-University, Giessen, Germany. Wagenlehner@AOL.com
A prudent antibiotic policy is crucial for prevalent urinary tract infections (UTIs) and male genital infections. Choosing the right antibiotic depends on infection type, considering pharmacokinetic and pharmacodynamic factors for effective treatment.
Area of Science:
- Infectious Diseases
- Pharmacology
- Urology
Background:
- Urinary tract infections (UTIs) and male genital infections are highly prevalent, necessitating a well-defined antibiotic policy with significant societal impact.
- Effective management relies on clinical classification into uncomplicated cystitis, uncomplicated pyelonephritis, complicated UTI, and genital infections.
- Antibiotic selection must integrate pharmacokinetic and pharmacodynamic considerations for optimal therapeutic outcomes.
Purpose of the Study:
- To outline an evidence-based antibiotic policy for common genitourinary infections.
- To emphasize the importance of tailored antibiotic selection based on infection type and causative pathogens.
- To highlight the role of pharmacokinetic and pharmacodynamic properties in guiding treatment choices.
Main Methods:
- Review of current clinical classifications for UTIs and male genital infections.
- Analysis of pharmacokinetic and pharmacodynamic properties of various antibiotic classes.
- Consideration of antimicrobial susceptibility patterns for common pathogens, including fastidious organisms.
Main Results:
- For uncomplicated cystitis, antibiotics like fosfomycin trometamol, nitrofurantoin, and pivmecillinam are preferred to minimize antibiotic pressure.
- Complicated UTIs require broad-spectrum antibiotics such as penicillins with β-lactamase inhibitors, cephalosporins, carbapenems, fluoroquinolones, aminoglycosides, or cotrimoxazole, based on susceptibility testing.
- Genital infections, particularly prostatitis, benefit from antibiotics with favorable pharmacokinetic profiles, including fluoroquinolones and macrolides, while also considering susceptibility to fastidious organisms like Chlamydia and Mycoplasma.
Conclusions:
- A strategic antibiotic policy, informed by clinical classification and antimicrobial properties, is essential for managing UTIs and male genital infections.
- Prioritizing specific antibiotics for uncomplicated cystitis helps preserve the efficacy of broader-spectrum agents.
- Tailored antibiotic selection, considering pharmacokinetics and pathogen profiles, is critical for successful treatment of complicated UTIs and diverse genital infections.
More Related Videos
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Microbiota of the Urogenital Tract
Urinary Tract Infection IV: Nursing Management
Urinary Tract Infection I: Introduction
Urine Studies II: Urine Culture and Sensitivity Test
Acute Pyelonephritis II: Diagnostic Studies and Management

